⌘K
Loading ticker…
As of 2026-08-24, CeriBell, Inc. Common Stock (CBLL) has a 3-month relative strength percentile of 86 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 65. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 4.6%, relative volume 0.89×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
CBLL is in a stage 2 uptrend, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 21.9% / 24.5%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
CBLL is held by 15 ETFs as of May 2026. Top owner: VTWO at 0.01% weight, $3M notional. Top 3 carry $6M.
Held by 25 ETFs · $49M across latest filings · largest weight 1.55% (LFSC).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.01% | $3M | — |
| SCHASchwab U.S. Small-Cap ETF | 0.01% | $2M | — |
| LFSC | 1.55% | $2M | −0.15 pp |
| VHTVanguard Health Care ETF | 0.01% | $1M | — |
| VTWG | 0.03% | $464K | — |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.00% |
| $426K |
| — |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $222K | — |
| AVSC | 0.01% | $210K | — |
| VTHRVanguard Russell 3000 ETF | 0.00% | $41K | — |
| MSSM | 0.00% | $24K | — |
Showing 10 of 15 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CBLL Jan avg: -8.55% median: -8.55% win: 0% σ: 3.58% n: 2 2024-10-14 → 2026-07-31 | CBLL Feb avg: -4.21% median: -4.21% win: 50% σ: 7.36% n: 2 2024-10-14 → 2026-07-31 | CBLL Mar avg: -9.58% median: -9.58% win: 0% σ: 10.97% n: 2 2024-10-14 → 2026-07-31 | CBLL Apr avg: -3.13% median: -3.13% win: 50% σ: 18.54% n: 2 2024-10-14 → 2026-07-31 | CBLL May avg: -2.00% median: -2.00% win: 50% σ: 9.16% n: 2 2024-10-14 → 2026-07-31 | CBLL Jun avg: 8.42% median: 8.42% win: 100% σ: 4.24% n: 2 2024-10-14 → 2026-07-31 | CBLL Jul avg: -16.08% median: -16.08% win: 0% σ: 9.95% n: 2 2024-10-14 → 2026-07-31 | CBLL Aug avg: -17.85% median: -17.85% win: 0% σ: 0.00% n: 1 2024-10-14 → 2026-07-31 (current) | CBLL Sep avg: -2.87% median: -2.87% win: 0% σ: 0.00% n: 1 2024-10-14 → 2026-07-31 | CBLL Oct avg: 2.19% median: 2.19% win: 50% σ: 4.20% n: 2 2024-10-14 → 2026-07-31 | CBLL Nov avg: 29.18% median: 29.18% win: 100% σ: 27.82% n: 2 2024-10-14 → 2026-07-31 | CBLL Dec avg: 9.56% median: 9.56% win: 50% σ: 27.82% n: 2 2024-10-14 → 2026-07-31 |